MEGAN NG: Open Payments
NPI 1699387787 · CRESTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$987 in 30 payments from 8 companies in 2025. Trend: 2023 $1,185 · 2024 $332 · 2025 $987
Food & beverage: $987
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $382 |
| HARMONY BIOSCIENCES LLC | 16 | $302 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $163 |
| GENZYME CORPORATION | 2 | $47 |
| Resmed Corp | 1 | $32 |
| Verona Pharma, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $18 |
Products named: WAKIX, TEZSPIRE, OFEV, FASENRA, DUPIXENT, AIRSENSE, JASCAYD, Ohtuvayre.
Industry payments across IA — which companies pay providers there.
